- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVS
Recent news which mentions NVS
3 Biotech Stocks That Sank in 2021 but Could Soar in 2022
December 26, 2021
From Motley Fool
Europe stocks beat back omicron worries to rise alongside global stocks
December 23, 2021
Tickers
NVS
From MarketWatch
FDA Approves Alnylam - Novartis' Leqvio As the First siRNA To Reduce Bad Cholesterol
December 23, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
December 23, 2021
From Benzinga
What's Happening With Allarity Therapeutics Stock Today?
December 22, 2021
From Benzinga
Novartis to purchase British biotech Gyroscope, a gene-therapy company
December 22, 2021
Tickers
NVS
Tags
NVS
From MarketWatch
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
December 22, 2021
From Benzinga
A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of GDP Report
December 22, 2021
From Benzinga
From Benzinga
The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More
December 17, 2021
From Benzinga
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
December 16, 2021
From Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
December 16, 2021
From Benzinga
From InvestorPlace
Could This Soaring Biotech Stock Make You Rich?
December 15, 2021
From Motley Fool
Molecular Partners Inks License Deal With Novartis For $580M
December 14, 2021
From Benzinga
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
From Benzinga
From InvestorPlace
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
December 13, 2021
From Benzinga
7 CEOs That Ought to Follow Jack Dorsey Out the Door
December 10, 2021
From InvestorPlace
Novartis Reveals Two Year Results From Beovu Trial In Diabetic Macular Edema Patients
December 09, 2021
From Benzinga
Novartis' New Kisqali Data Shows Consistent Overall Survival Benefit Across Metastatic Breast Cancer Settings
December 08, 2021
Tickers
NVS
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021
December 03, 2021
From Benzinga
Why Aurinia Pharmaceuticals Stock Bolted Higher Today
December 02, 2021
From Motley Fool
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
December 02, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.